The Metsera deal is about winning the obesity drugs' market that’s expected to reach US$100 billion by 2030. Read more at ...

Pfizer And Metsera Enter Into Merger Agreement Amendment Metsera's Board Of Directors Reaffirms Support Of Merger With Pfizer. <li /> Revised transaction values Metsera at up to $86.25 per share <li ...

Pfizer Inc. has agreed to buy Metsera Inc. for $10 billion, surpassing Novo Nordisk in a competitive bidding war. Details of ...

Pfizer appeared to have locked up the acquisition in September before Novo jumped in last week with an unsolicited offer, ...

Metsera, an obesity drug developer, has accepted a $10 billion acquisition offer from pharmaceutical giant Pfizer, potentially concluding a bidding war with Novo Nordisk.

Pfizer Inc. has agreed to buy Metsera Inc. in a $10 billion deal, following a tumultuous bidding war with Novo Nordisk A/S ...

After a bidding war erupted between Pfizer and Novo Nordisk over the fledgling obesity drug maker, Metsera decided to side with its original suitor.

Pfizer has won the bidding war against Novo Nordisk to acquire obesity-drug biotech Metsera. The pharma giant upped its offer ...

Pfizer prevailed over Novo Nordisk after an unusual bidding war for the weight-loss startup.

NEW YORK/LONDON (Reuters) -A bidding war over U.S. biotech Metsera was coming to a head on Thursday, with Danish drugmaker ...

Pfizer has submitted a sweetened bid for obesity drug developer Metsera, as its fight against rival Novo Nordisk escalates, ...

Democratic Senate Minority Leader Chuck Schumer proposed extending expiring health-care subsidies for one year as part of a measure to reopen the government, in a move aimed at breaking the monthlong ...